133 related articles for article (PubMed ID: 36425063)
1. GATA-3-dependent Gene Transcription is Impaired upon HDAC Inhibition.
Geng X; Wang C; Abdelrahman S; Perera T; Saed B; Hu YS; Wolfe A; Reneau J; Murga-Zamalloa C; Wilcox RA
Clin Cancer Res; 2024 Mar; 30(5):1054-1066. PubMed ID: 38165708
[TBL] [Abstract][Full Text] [Related]
2. Decrypting lysine deacetylase inhibitor action and protein modifications by dose-resolved proteomics.
Chang YC; Gnann C; Steimbach RR; Bayer FP; Lechner S; Sakhteman A; Abele M; Zecha J; Trendel J; The M; Lundberg E; Miller AK; Kuster B
Cell Rep; 2024 May; 43(6):114272. PubMed ID: 38795348
[TBL] [Abstract][Full Text] [Related]
3. New insights into possible HDAC inhibitor resistance in DLBCL - Comment on 'defining cellular responses to HDAC-selective inhibitors reveals that efficient targeting of HDAC3 is required to elicit cytotoxicity and overcome naïve resistance to pan-HDACi in diffuse large B cell lymphoma' by Havas et al.
Kiesslich T; Mayr C; Bekric D; Neureiter D
Transl Oncol; 2024 Jun; 44():101820. PubMed ID: 38641373
[No Abstract] [Full Text] [Related]
4. DOT1L regulates chromatin reorganization and gene expression during sperm differentiation.
Blanco M; El Khattabi L; Gobé C; Crespo M; Coulée M; de la Iglesia A; Ialy-Radio C; Lapoujade C; Givelet M; Delessard M; Seller-Corona I; Yamaguchi K; Vernet N; Van Leeuwen F; Lermine A; Okada Y; Daveau R; Oliva R; Fouchet P; Ziyyat A; Pflieger D; Cocquet J
EMBO Rep; 2023 Jun; 24(6):e56316. PubMed ID: 37099396
[TBL] [Abstract][Full Text] [Related]
5. DOT-1.1 (DOT1L) deficiency in
Liontis T; Verma K; Grishok A
BBA Adv; 2023; 3():100080. PubMed ID: 37082252
[TBL] [Abstract][Full Text] [Related]
6. HDAC inhibitors for the treatment of cutaneous T-cell lymphomas.
Rangwala S; Zhang C; Duvic M
Future Med Chem; 2012 Mar; 4(4):471-86. PubMed ID: 22416775
[TBL] [Abstract][Full Text] [Related]
7. Topical and Systemic Formulation Options for Cutaneous T Cell Lymphomas.
Fujimura T; Amagai R; Kambayashi Y; Aiba S
Pharmaceutics; 2021 Feb; 13(2):. PubMed ID: 33540765
[TBL] [Abstract][Full Text] [Related]
8. DOT1L inhibition does not modify the sensitivity of cutaneous T cell lymphoma to pan-HDAC inhibitors
Kwesi-Maliepaard EM; Malik M; van Welsem T; van Doorn R; Vermeer MH; Vlaming H; Jacobs H; van Leeuwen F
Front Genet; 2022; 13():1032958. PubMed ID: 36425063
[TBL] [Abstract][Full Text] [Related]
9. Conserved crosstalk between histone deacetylation and H3K79 methylation generates DOT1L-dose dependency in HDAC1-deficient thymic lymphoma.
Vlaming H; McLean CM; Korthout T; Alemdehy MF; Hendriks S; Lancini C; Palit S; Klarenbeek S; Kwesi-Maliepaard EM; Molenaar TM; Hoekman L; Schmidlin TT; Altelaar AM; van Welsem T; Dannenberg JH; Jacobs H; van Leeuwen F
EMBO J; 2019 Jul; 38(14):e101564. PubMed ID: 31304633
[TBL] [Abstract][Full Text] [Related]
10. Involvement of p53 Acetylation in Growth Suppression of Cutaneous T-Cell Lymphomas Induced by HDAC Inhibition.
Yu X; Li H; Zhu M; Hu P; Liu X; Qing Y; Wang X; Wang H; Wang Z; Xu J; Tan R; Guo Q; Hui H
J Invest Dermatol; 2020 Oct; 140(10):2009-2022.e4. PubMed ID: 32119867
[TBL] [Abstract][Full Text] [Related]
11. Prognostic significance of the therapeutic targets histone deacetylase 1, 2, 6 and acetylated histone H4 in cutaneous T-cell lymphoma.
Marquard L; Gjerdrum LM; Christensen IJ; Jensen PB; Sehested M; Ralfkiaer E
Histopathology; 2008 Sep; 53(3):267-77. PubMed ID: 18671804
[TBL] [Abstract][Full Text] [Related]
12. Synergy of BCL2 and histone deacetylase inhibition against leukemic cells from cutaneous T-cell lymphoma patients.
Cyrenne BM; Lewis JM; Weed JG; Carlson KR; Mirza FN; Foss FM; Girardi M
Blood; 2017 Nov; 130(19):2073-2083. PubMed ID: 28972015
[TBL] [Abstract][Full Text] [Related]
13. Mechanism, Consequences, and Therapeutic Targeting of Abnormal IL15 Signaling in Cutaneous T-cell Lymphoma.
Mishra A; La Perle K; Kwiatkowski S; Sullivan LA; Sams GH; Johns J; Curphey DP; Wen J; McConnell K; Qi J; Wong H; Russo G; Zhang J; Marcucci G; Bradner JE; Porcu P; Caligiuri MA
Cancer Discov; 2016 Sep; 6(9):986-1005. PubMed ID: 27422033
[TBL] [Abstract][Full Text] [Related]
14. A toolbox for class I HDACs reveals isoform specific roles in gene regulation and protein acetylation.
Hess L; Moos V; Lauber AA; Reiter W; Schuster M; Hartl N; Lackner D; Boenke T; Koren A; Guzzardo PM; Gundacker B; Riegler A; Vician P; Miccolo C; Leiter S; Chandrasekharan MB; Vcelkova T; Tanzer A; Jun JQ; Bradner J; Brosch G; Hartl M; Bock C; Bürckstümmer T; Kubicek S; Chiocca S; Bhaskara S; Seiser C
PLoS Genet; 2022 Aug; 18(8):e1010376. PubMed ID: 35994477
[TBL] [Abstract][Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
